Quick Answer
HAEMONETICS CORP reported Diluted EPS of $3.31 per share for fiscal year 2025.
HAEMONETICS CORP Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $3.31 | +44.5% |
| 2024 | $2.29 | +2.2% |
| 2023 | $2.24 | +166.7% |
| 2022 | $0.84 | -45.8% |
| 2021 | $1.55 | +4.7% |
| 2020 | $1.48 | +42.3% |
| 2019 | $1.04 | +22.4% |
| 2018 | $0.85 | +266.7% |
| 2017 | -$0.51 | +53.2% |
| 2016 | -$1.09 | -440.6% |
| 2015 | $0.32 | -52.2% |
| 2014 | $0.67 | -9.5% |
| 2013 | $0.74 | -43.1% |
| 2012 | $1.30 | -16.7% |
| 2011 | $1.56 | -30.4% |
| 2010 | $2.24 | -1.3% |
| 2009 | $2.27 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.95 | +28.4% | +17.3% |
| September 30, 2025 | $0.81 | +22.7% | +15.7% |
| June 30, 2025 | $0.70 | -5.4% | -5.4% |
| December 31, 2024 | $0.74 | +21.3% | +12.1% |
| September 30, 2024 | $0.66 | +37.5% | -10.8% |
| June 30, 2024 | $0.74 | -7.5% | +21.3% |
| December 31, 2023 | $0.61 | -4.7% | +27.1% |
| September 30, 2023 | $0.48 | -25.0% | -40.0% |
- HAEMONETICS CORP showed an increase of +44.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, HAEMONETICS CORP’s diluted eps has grown by 45.8% (from $2.27 per share to $3.31 per share).
- The most recent figure is from HAEMONETICS CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: